Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Vaccine targeting IDO safe and well tolerated in first-in-human study

Oct. 29, 2013

Mologen files application in Belgium to conduct trial in small cell lung cancer

Oct. 29, 2013

FDA grants orphan drug designation to Aduro's immunotherapy for pancreatic cancer

Oct. 23, 2013

Antibody DCBPR-01101 targets globo H for breast cancer treatment

Oct. 23, 2013

Updated immunological results published from phase I evaluation of AE37 prostate cancer vaccine

Oct. 23, 2013

FDA submission for Arzerra in previously untreated CLL

Oct. 22, 2013

Seattle Genetics begins phase I study of SGN-LIV1A

Oct. 22, 2013

Team of Japanese researchers designs novel antibodies for multiple myeloma

Oct. 22, 2013

Phase Ia VGX-100 trial completes patient enrollment

Oct. 18, 2013

Lytix Biopharma receives clearance to conduct phase I study of LTX-315

Oct. 17, 2013

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...